Pàgina inicial > Resultats de la cerca: van der Werf, S.
  Consells de cerca
Cerca avançada
Cerca col·leccions:
Ordena'ls per: Mostrar els resultats: Format de visualizació:
Resultats globals: 5 registres trobats en 0.02 segons.
Articles, 5 registres trobats
Articles 5 registres trobats  
1.
10 p, 856.3 KB Analysis of data collected in the European Society for Blood and Marrow Transplantation (EBMT) Registry on a cohort of lymphoma patients receiving plerixafor / Sureda, Anna (Institut Català d'Oncologia) ; Chabannon, Christian (Institut Paoli-Calmettes) ; Masszi, Tamás (Semmelweis University) ; Pohlreich, David (Charles University Hospital) ; Scheid, Christof (University of Cologne) ; Thieblemont, Catherine (Hôpital Saint-Louis) ; Wahlin, Björn E. (Karolinska University Hospital and Karolinska Institutet (Suecia)) ; Sakellari, Ioanna (George Papanicolaou General Hospital) ; Russell, Nigel (Nottingham University Hospital) ; Janikova, Andrea (University Hospital Brno (República Txeca)) ; Dabrowska-Iwanicka, Anna (Maria Sklodowska-Curie Institute-Oncology Center) ; Touzeau, Cyrille (CHU Nantes) ; Esquirol, Albert (Institut d'Investigació Biomèdica Sant Pau) ; Jantunen, Esa (University of Eastern Finland and Kuopio University Hospital) ; van der Werf, Steffie (EBMT Data Office) ; Bosman, Paul (EBMT Data Office) ; Boumendil, Ariane (EBMT Statistical Unit) ; Liu, Qianying (Sanofi Genzyme) ; Celanovic, Marina (Sanofi Genzyme) ; Montoto, Silvia (St Bartholomew's Hospital) ; Dreger, Peter (University of Heidelberg) ; Universitat Autònoma de Barcelona
Plerixafor + granulocyte-colony stimulating factor (G-CSF) is administered to patients with lymphoma who are poor mobilizers of hematopoietic stem cells (HSCs) in Europe. This international, multicenter, non-interventional registry study (NCT01362972) evaluated long-term follow-up of patients with lymphoma who received plerixafor for HSC mobilization versus other mobilization methods. [...]
2020 - 10.1038/s41409-019-0693-z
Bone marrow transplantation, Vol. 55 Núm. 3 (january 2020) , p. 613-622  
Registre complet - Creative Commons
2.
7 p, 473.0 KB Association of uric acid levels before start of conditioning with mortality after allogeneic hematopoietic stem cell transplantation - a prospective, non-interventional study of the EBMT Transplant Complication Working Party / Penack, Olaf (Charité - Universitätsmedizin Berlin) ; Peczynski, Christophe (EBMT Statistical Unit) ; van der Werf, Steffie (EBMT Data Office) ; Finke, Jürgen (University of Freiburg) ; Ganser, Arnold (Hannover Medical School) ; Schoemans, Helene (University Hospitals Leuven (Bèlgica)) ; Pavlu, Jiri (Imperial College London) ; Niittyvuopio, Riitta. (HUCH Comprehensive Cancer Center) ; Schroyens, Wilfried (University Hospital Antwerp (Bèlgica)) ; Kaynar, Leylagül (Erciyes University Medical Faculty) ; Blau, Igor W. (Charité - Universitätsmedizin Berlin) ; van der Velden, Walter (Radboud University - Nijmegen Medical Centre) ; Sierra, Jorge (Institut d'Investigació Biomèdica Sant Pau) ; Cortelezzi, Agostino (Fondazione IRCCS - Ca'Granda) ; Wulf, Gerald (Universitätsklinikum Göttingen) ; Turlure, Pascal (CHRU Limoges) ; Rovira, Montserrat (Hospital Clínic i Provincial de Barcelona) ; Ozkurt, Zubeydenur (Gazi University) ; Pascual-Cascon, Maria J. (Hospital Regional Universitario de Málaga) ; Moreira, Maria C. (Instituto National do Cancer) ; Clausen, Johannes (Ordensklinikum Linz Elisabethinen) ; Greinix, Hildegard (LKH - University Hospital Graz) ; Duarte, Rafael F. (Hospital Universitario Puerta de Hierro Majadahonda (Madrid)) ; Basak, Grzegorz (Medical University of Warsaw) ; Universitat Autònoma de Barcelona
ric acid is a danger signal contributing to inflammation. Its relevance to allogeneic stem cell transplantation (alloSCT) derives from preclinical models where the depletion of uric acid led to improved survival and reduced graft-versus-host disease (GvHD). [...]
2020 - 10.3324/haematol.2019.228668
Haematologica, Vol. 105 Núm. 7 (january 2020) , p. 1977-1983  
Registre complet - Creative Commons
3.
8 p, 3.0 MB Association of Serum Ferritin Levels Before Start of Conditioning With Mortality After alloSCT - A Prospective, Non-interventional Study of the EBMT Transplant Complications Working Party / Penack, Olaf (Charité - Universitätsmedizin Berlin) ; Peczynski, Christophe (EBMT Statistical Unit) ; van der Werf, Steffie (EBMT Data Office) ; Finke, Jürgen (University of Freiburg) ; Ganser, Arnold (Hannover Medical School) ; Schoemans, Helene (University Hospitals Leuven (Bèlgica)) ; Pavlu, Jiri (Imperial College London) ; Niittyvuopio, Riitta (HUCH Comprehensive Cancer Center) ; Schroyens, W.ilfried (University Hospital Antwerp (Bèlgica)) ; Kaynar, Leylagül (Erciyes University) ; Blau, Igor W. (Department of Hematology. Oncology. and Tumor Immunology) ; van der Velden, Walter J.F.M. (Radboud University) ; Malouf Sierra, Jorge 1971- (Institut d'Investigació Biomèdica Sant Pau) ; Cortelezzi, Agostini (University of Milan) ; Wulf, Gerald (Universitätsklinikum Göttingen) ; Turlure, Pascal (CHRU Limoges) ; Rovira Argelagués, Montserrat (Hospital Clínic i Provincial de Barcelona) ; Ozkurt, Zubeydenur (Gazi University) ; Pascual-Cascon, Maria J. (Hospital Regional Universitario de Málaga) ; Moreira, Maria C. (Instituto National do Cancer) ; Clausen, Johannes (Ordensklinikum Linz Elisabethinen) ; Greinix, Hildegard (Medical University of Graz) ; Duarte, Rafael F. (Hospital Universitario Puerta de Hierro Majadahonda (Madrid)) ; Basak, Grzegorz (Medical University of Warsaw) ; Universitat Autònoma de Barcelona
Elevated serum ferritin levels occur due to iron overload or during inflammation and macrophage activation. A correlation of high serum ferritin levels with increased mortality after alloSCT has been suggested by several retrospective analyses as well as by two smaller prospective studies. [...]
2020 - 10.3389/fimmu.2020.00586
Frontiers in immunology, Vol. 11 (15 2020) , p. 586  
Registre complet - Creative Commons
4.
12 p, 2.3 MB The phylogenetic landscape and nosocomial spread of the multidrug-resistant opportunist Stenotrophomonas maltophilia / Gröschel, Matthias I. (University Medical Center Groningen. Department of Pulmonary Diseases & Tuberculosis) ; Meehan, Conor J. (University of Bradford. School of Chemistry and Bioscience) ; Barilar, Ivan (Research Center Borstel. Molecular and Experimental Mycobacteriology) ; Diricks, Margo (BioMérieux) ; Gonzaga, Aitor (Leibniz Institute DSMZ. German Collection of Microorganisms and Cell Cultures) ; Steglich, Matthias (Leibniz Institute DSMZ. German Collection of Microorganisms and Cell Cultures) ; Conchillo-Solé, Oscar (Universitat Autònoma de Barcelona. Institut de Biotecnologia i de Biomedicina "Vicent Villar Palasí") ; Scherer, Isabell-Christin (Universitätsklinikum Schleswig-Holstein (Alemanya)) ; Mamat, Uwe (Cellular Microbiology, Research Center Borstel) ; Luz, Christian F. (University Medical Center Groningen. Department of Medical Microbiology and Infection Prevention) ; De Bruyne, Katrien (bioMérieux, Applied Maths NV) ; Utpatel, Christian (Research Center Borstel. Molecular and Experimental Mycobacteriology) ; Yero, Daniel (Universitat Autònoma de Barcelona. Departament de Genètica i de Microbiologia) ; Gibert, Isidre (Universitat Autònoma de Barcelona. Departament de Genètica i de Microbiologia) ; Daura i Ribera, Xavier (Universitat Autònoma de Barcelona. Institut de Biotecnologia i de Biomedicina "Vicent Villar Palasí") ; Kampmeier, Stefanie (University Hospital of Münster (Alemanya)) ; Rahman, Nurdyana Abdul (Singapore General Hospital. Department of Microbiology) ; Kresken, Michael (Rheinische Fachhochschule Köln gGmbH) ; van der Werf, Tjip S. (University Medical Center Groningen. Department of Pulmonary Diseases & Tuberculosis) ; Alio, Ifey (University of Hamburg. Department of Microbiology and Biotechnology) ; Streit, Wolfgang R. (University of Hamburg. Department of Microbiology and Biotechnology) ; Zhou, Kai (Jinan University. Second Clinical Medical College) ; Schwartz, Thomas (Karlsruhe Institute of Technology) ; Rossen, John W. A. (University Medical Center Groningen. Department of Medical Microbiology and Infection Prevention) ; Farhat, Maha R. (Massachusetts General Hospital (Boston)) ; Schaible, Ulrich E. (Leibniz Research Alliance Infections'21) ; Nübel, Ulrich (Technical University. Braunschweig Integrated Center of Systems Biology) ; Rupp, Jan (German Center for Infection Research) ; Steinmann, Joerg (Paracelsus Medical Private University) ; Niemann, Stefan (Leibniz Research Alliance Infections'21) ; Kohl, Thomas A. (German Center for Infection Research)
Recent studies portend a rising global spread and adaptation of human- or healthcare-associated pathogens. Here, we analyse an international collection of the emerging, multidrug-resistant, opportunistic pathogen Stenotrophomonas maltophilia from 22 countries to infer population structure and clonality at a global level. [...]
2020 - 10.1038/s41467-020-15123-0
Nature communications, Vol. 11 (April 2020) , art. 2044  
Registre complet - Creative Commons
5.
9 p, 608.4 KB Non-Steroidal Anti-inflammatory Drugs As Host-Directed Therapy for Tuberculosis : A Systematic Review / Kroesen, Vera Marie (Institut Germans Trias i Pujol. Hospital Universitari Germans Trias i Pujol) ; Gröschel, Matthias I. (Department of Infectious Diseases, University Medical Center Groningen, University of Groningen) ; Martinson, Neil (Perinatal HIV Research Unit, University of Witwatersrand) ; Zumla, Alimuddin (Department of Microbiology, University College London Hospitals NHS Foundation Trust) ; Maeurer, Markus (Karolinska Institutet (Estocolm, Suècia). Department of Laboratory Medicine) ; van der Werf, Tjip S. (Department of Infectious Diseases, University Medical Center Groningen, University of Groningen) ; Vilaplana, Cristina (Institut Germans Trias i Pujol) ; Universitat Autònoma de Barcelona
Lengthy, antimicrobial therapy targeting the pathogen is the mainstay of conventional tuberculosis treatment, complicated by emerging drug resistances. Host-directed therapies, including non-steroidal anti-inflammatory drugs (NSAIDs), in contrast, target host factors to mitigate disease severity. [...]
2017 - 10.3389/fimmu.2017.00772
Frontiers in immunology, Vol. 8 (june 2017)  
Registre complet - Creative Commons

Us interessa rebre alertes sobre nous resultats d'aquesta cerca?
Definiu una alerta personal via correu electrònic o subscribiu-vos al canal RSS.
Dipòsit Digital de Documents de la UAB :: Cerca :: Lliura :: Personalitza :: Ajuda
Powered by Invenio v1.1.6
Mantingut per ddd.bib@uab.cat  :: Metadades subjectes a:
Col·laborem